- Report
- September 2023
- 135 Pages
Global
From €4352EUR$4,500USD£3,730GBP
- Report
- January 2024
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- February 2024
- 250 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 141 Pages
Global
From €3771EUR$3,899USD£3,231GBP
- Report
- February 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- February 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- February 2024
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- January 2024
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- December 2023
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- April 2024
- 136 Pages
Global
From €3771EUR$3,899USD£3,231GBP
- Report
- November 2023
- 182 Pages
Global
From €4739EUR$4,900USD£4,061GBP
- Report
- March 2024
- 200 Pages
Global
From €4013EUR$4,150USD£3,440GBP
- Report
- February 2024
- 112 Pages
Global
From €4594EUR$4,750USD£3,937GBP
- Report
- November 2023
- 148 Pages
Global
From €4303EUR$4,450USD£3,688GBP
- Report
- March 2024
- 200 Pages
Global
From €4013EUR$4,150USD£3,440GBP
The Inflammation market within the context of Allergy and Immunology is a rapidly growing field of research and development. It focuses on the study of the body's immune system and its response to allergens, pathogens, and other foreign substances. This includes the development of treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. The market is driven by the increasing prevalence of allergies and autoimmune diseases, as well as the need for more effective treatments.
The Inflammation market is composed of a variety of companies, ranging from pharmaceuticals to biotechnology firms. These companies are focused on developing new treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. Examples of companies in this market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more